Regioselective N1-ribosylation of hydantoin: synthesis and properties of the first contracted uridine analogCHEMICAL COMMUNICATIONSIF4.22025-01-010OA
Hydrolytic (in)stability of phosphate isosteresEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92022-12-011PRE
β-Cyanuryl Ribose, β-Barbituryl Ribose, and 6-Azauridine as Uridine MimeticsACS OMEGAIF4.32020-11-255OAAI
Specific, Sensitive, and Quantitative Detection of HER-2 mRNA Breast Cancer Marker by Fluorescent Light-Up Hybridization ProbesBIOCONJUGATE CHEMISTRYIF3.92020-03-256PREAI
Applying styryl quinolinium fluorescent probes for imaging of ribosomal RNA in living cellsDYES AND PIGMENTSIF4.22020-03-0119PREAI
Addressing regio- and stereo-specificity challenges in the synthesis of nucleoside 2′,3′-cyclic monophosphate analogs - a rapid and facile synthesis of nucleoside-2′,3′-O,O-phosphoro-thioate or -selenoate, and elucidation of the origin of the rare specificityCHEMICAL COMMUNICATIONSIF4.22020-01-013PREAI
Structure-activity relationship study of NPP1 inhibitors based on uracil-N1-(methoxy)ethyl-β-phosphate scaffoldEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92019-12-017PREAI
Aminomethylene-Phosphonate Analogue as a Cu(II) Chelator: Characterization and Application as an Inhibitor of Oxidation Induced by Cu(II)-Prion Peptide Complex (vol 58, pg 8995, 2019)INORGANIC CHEMISTRYIF4.72019-09-030OAAI
Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytes (vol 15, pg 247, 2019)PURINERGIC SIGNALLINGIF2.42019-07-200OAAI
An oligonucleotide probe incorporating the chromophore of green fluorescent protein is useful for the detection of HER-2 mRNA breast cancer markerEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92019-07-0110PREAI
Aminomethylene-Phosphonate Analogue as a Cu(II) Chelator: Characterization and Application as an Inhibitor of Oxidation Induced by the Cu(II)-Prion Peptide ComplexINORGANIC CHEMISTRYIF4.72019-06-252PREAI
Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytesPURINERGIC SIGNALLINGIF2.42019-04-258OAAI
A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonistPURINERGIC SIGNALLINGIF2.42018-07-1715OAAI
Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5′-Pα,α-Dithiophosphate AnaloguesJOURNAL OF MEDICINAL CHEMISTRYIF6.82018-04-2227PREAI
A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD MiceJOURNAL OF ALZHEIMERS DISEASEIF3.12017-04-286PREAI
Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5'-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of ActionJOURNAL OF MEDICINAL CHEMISTRYIF6.82015-10-1615PREAI
Synthesis and structure-activity relationship of uracil nucleotide derivatives towards the identification of human P2Y6 receptor antagonistsBIOORGANIC & MEDICINAL CHEMISTRYIF32015-09-0122PREAI
AN ENPP1-SPECIFIC INHIBITOR ATTENUATES EXTRACELLULAR ECTO-PYROPHOSPHATASE ACTIVITY IN HUMAN OSTEOARTHRITIC CARTILAGEANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-010PREAI
Adenosine/guanosine-3′, 5′-bis-phosphates as biocompatible and selective Zn2+-ion chelators. Characterization and comparison with adenosine/guanosine-5′-di-phosphateDALTON TRANSACTIONSIF3.32015-01-014PREAI
Novel crown-ether-methylenedipho-sphonotetrathioate hybrids as Zn(II) chelatorsDALTON TRANSACTIONSIF3.32015-01-010PREAI